170 related articles for article (PubMed ID: 29892075)
1. Potent block of potassium channels by MEK inhibitor U0126 in primary cultures and brain slices.
Wang JZ; Long C; Li KY; Xu HT; Yuan LL; Wu GY
Sci Rep; 2018 Jun; 8(1):8808. PubMed ID: 29892075
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of K+ channel inactivation by MEK inhibitor U0126.
Yuan LL; Chen X; Kunjilwar K; Pfaffinger P; Johnston D
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C165-71. PubMed ID: 16135544
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus.
Zhang HT; Zhao Y; Huang Y; Dorairaj NR; Chandler LJ; O'Donnell JM
Neuropsychopharmacology; 2004 Aug; 29(8):1432-9. PubMed ID: 15114341
[TBL] [Abstract][Full Text] [Related]
4. Role of ERK1/2 signaling pathways in 4-aminopyridine-induced rat pulmonary vasoconstriction.
Han W; Tang X; Wu H; Liu Y; Zhu D
Eur J Pharmacol; 2007 Aug; 569(1-2):138-44. PubMed ID: 17537430
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus.
Matsuzaki K; Miyazaki K; Sakai S; Yawo H; Nakata N; Moriguchi S; Fukunaga K; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
Eur J Pharmacol; 2008 Jan; 578(2-3):194-200. PubMed ID: 17976577
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms underlying the repolarization of narrow and wide action potentials in pyramidal cells and interneurons of cat motor cortex.
Chen W; Zhang JJ; Hu GY; Wu CP
Neuroscience; 1996 Jul; 73(1):57-68. PubMed ID: 8783229
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuronal degenerin/epithelial Na+ channels by the multiple sclerosis drug 4-aminopyridine.
Boiko N; Kucher V; Eaton BA; Stockand JD
J Biol Chem; 2013 Mar; 288(13):9418-27. PubMed ID: 23404498
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells.
Huang CW; Huang CC; Liu YC; Wu SN
Epilepsia; 2004 Jul; 45(7):729-36. PubMed ID: 15230694
[TBL] [Abstract][Full Text] [Related]
10. Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells.
Grant ER; Errico MA; Emanuel SL; Benjamin D; McMillian MK; Wadsworth SA; Zivin RA; Zhong Z
Biochem Pharmacol; 2001 Aug; 62(3):283-96. PubMed ID: 11434901
[TBL] [Abstract][Full Text] [Related]
11. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons.
Vydyanathan A; Wu ZZ; Chen SR; Pan HL
J Neurophysiol; 2005 Jun; 93(6):3401-9. PubMed ID: 15647393
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Ca(2+) action potential channels by the MEK inhibitor PD98059.
Gould MC; Stephano JL
Exp Cell Res; 2000 Oct; 260(1):175-9. PubMed ID: 11010822
[TBL] [Abstract][Full Text] [Related]
13. Potassium currents during the action potential of hippocampal CA3 neurons.
Mitterdorfer J; Bean BP
J Neurosci; 2002 Dec; 22(23):10106-15. PubMed ID: 12451111
[TBL] [Abstract][Full Text] [Related]
14. U0126 prevents ERK pathway phosphorylation and interleukin-1beta mRNA production after cerebral ischemia.
Wang ZQ; Chen XC; Yang GY; Zhou LF
Chin Med Sci J; 2004 Dec; 19(4):270-5. PubMed ID: 15669185
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of glial K(+) currents by 4-AP.
Bordey A; Sontheimer H
J Neurophysiol; 1999 Dec; 82(6):3476-87. PubMed ID: 10601476
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes in the functional characteristics and expression of voltage-gated K+ channel currents in rat aortic myocytes.
Belevych AE; Beck R; Tammaro P; Poston L; Smirnov SV
Cardiovasc Res; 2002 Apr; 54(1):152-61. PubMed ID: 12062371
[TBL] [Abstract][Full Text] [Related]
17. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
18. Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes.
Pereira DB; Carvalho AP; Duarte CB
Neuropharmacology; 2002 Jan; 42(1):9-19. PubMed ID: 11750912
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of K(+) channel blockers on frequency-dependent action potential broadening in supraoptic neurons.
Hlubek MD; Cobbett P
Brain Res Bull; 2000 Sep; 53(2):203-9. PubMed ID: 11044597
[TBL] [Abstract][Full Text] [Related]
20. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
Ge X; Fu YM; Meadows GG
Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
